Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Clinical Efficacy of AZVUDINE: Randomized, Double-blind, Placebo-controlled Study in Mild Stage Patients Infected With the SARS-CoV-2 Virus

NCT05033145 is registered in ClinicalTrials.gov with HRH Pharmaceuticals Limited as lead sponsor.

NCT NCT05033145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05033145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Clinical Efficacy of AZVUDINE: Randomized, Double-blind, Placebo-controlled Study in Mild Stage Patients Infected With the SARS-CoV-2 Virus
Lead sponsor
HRH Pharmaceuticals Limited
Phase
Phase 3
Overall status
Completed
Start date
January 15, 2022
Completion date
July 27, 2022
Enrollment
312 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19